Runben Biotechnology Co Ltd
SSE:603193
Wall Street
Price Targets
Price Targets Summary
Runben Biotechnology Co Ltd
According to Wall Street analysts, the average 1-year price target for
Runben Biotechnology Co Ltd
is 39.6 CNY
with a low forecast of 32.87 CNY and a high forecast of 49.91 CNY.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Runben Biotechnology Co Ltd's stock price target?
Price Target
39.6
CNY
According to Wall Street analysts, the average 1-year price target for
Runben Biotechnology Co Ltd
is 39.6 CNY
with a low forecast of 32.87 CNY and a high forecast of 49.91 CNY.
What is Runben Biotechnology Co Ltd's Revenue forecast?
Projected CAGR
23%
For the last 1 year the
compound annual growth rate for
Runben Biotechnology Co Ltd's revenue is
28%.
The projected
CAGR
for the next 3 years is
23%.
What is Runben Biotechnology Co Ltd's Operating Income forecast?
Projected CAGR
21%
For the last 1 year the
compound annual growth rate for
Runben Biotechnology Co Ltd's operating income is
25%.
The projected
CAGR
for the next 3 years is
21%.
What is Runben Biotechnology Co Ltd's Net Income forecast?
Projected CAGR
17%
For the last 1 year the
compound annual growth rate for
Runben Biotechnology Co Ltd's net income is
33%.
The projected
CAGR
for the next 3 years is
17%.
